Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact... ...
http://www.business-standard.com/article/companies/biocon-monetisation-of-drug-pipeline-in-emerging-markets-to-boost-earnings-118041701457_1.htmlThe house is of the view that H2 seems to be strong for the company and Mylan with monetisation prospects of biosimilar pipeline improving. The... ...
https://www.moneycontrol.com/news/stocks-views/morgan-stanley-overweightbiocon-sees-significant-upsideits-biosimilar-pipeline_10776561.htmlPosted by Equitymaster Asian share markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.5% while the Hang... ...
http://www.equitymaster.com/tm/tm.asp?date=4/12/2018&title=Indian-Share-Markets-Open-Flat-Metal--Energy-Stocks-DragMylan said its partner Biocon will receive economic benefit through this collaboration. ...
https://www.moneycontrol.com/news/business/biocon-partner-mylan-enters-pactfujifilm-to-commercialise-humira-biosimilareurope_10770121.html(Reuters) - Mylan NV will buy global marketing rights to an experimental multiple sclerosis treatment from Israel's Mapi Pharma, aiming to... ...
http://feeds.reuters.com/~r/reuters/INhealth/~3/JD06N1LAmhs/mylan-to-buy-ms-drug-marketing-rights-from-israels-mapi-pharma-idINKBN1HH1QR